From the Lab to Our Pockets, ChatGPT is Setting Standards for Public AI

 

For the last few months, millions of professionals, hobbyists, and curious folks have been enjoying ChatGPT, arguably the new zeitgeist and standard for public AI tools. Long before AI was a reality, we have been speculating about what it might look like in our lives. Arthur C. Clarke famously depicted AI going rogue with the AI character HAL 9000 in his 1968 novel 2001: A Space Odyssey. A decade later, George Lucas made us fall in love with AI characters with the duo R2-D2 and C3PO in his 1977 film Star Wars.

Ironically, what these two very different depictions of AI agreed upon was that AI was a powerful tool that was reserved for important tasks like space exploration or alien communication. Yet with the free release of ChatGPT in November of 2022, suddenly everyone has highly-responsive generative AI in their pocket ready to assist scientists, market small businesses and everything in between. The powerful tool of generative AI has been made free and readily available beyond some of our most far-flung depictions of the future.

Public AI could become a game changer in business and even our day-to-day lives simply because of that widespread availability. That’s why Asha Saxena, renowned AI scientist and CEO and founder of the network Women Leaders in Data and AI (WLDA) is excited at the prospect of mass public AI proliferation in our lifetimes.

Asha’s Thoughts:

“I am super excited about the time we are living in today. November 2022 was the time when ChatGPT came out. ChatGPT, generative AI has truly changed the way everyone is now interacting with AI that they never thought they would. Science really comes to the doorstep here when we are working with ChatGPT.

We always thought artificial intelligence will be kept in the labs or with the big organization, but today, every single person is engaged, involved, and is curious about how it’s gonna change our life, in healthcare education, how we become consumers or in transportation. So, I’m really excited about the time we live in and how ChatGPT and generative AI has changed the way we are engaging with artificial intelligence now and that’s it.”

Article written by Graham P. Johnson.

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More